Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1400 (LINC01400)

Target
LINC01400
Molecular classification
Long non-coding RNA, Intergenic lincRNA, lncRNA
01

Overview

Long intergenic non-protein coding RNA 1400 (LINC01400) is a member of the long non-coding RNA (lncRNA) class, specifically within the subclass of intergenic lincRNAs, which are RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and lack significant protein-coding potential[1][3][5][7][9]. LINC01400 is located on chromosome 9 (chr9:37072361-37075800, negative strand), with two transcript variants reported[3]. These lincRNAs can participate in regulation of gene expression at multiple levels, such as chromatin remodeling, transcription, and post-transcriptional processing; however, the specific function and disease relevance of LINC01400 remain uncharacterized with no published functional studies or established disease links[3][5][9]. LINC01400 does not encode a protein, is not a receptor, enzyme, or transporter, and is not considered a classical therapeutic target. There are currently no documented drugs or clinical applications targeting this lncRNA[1][3][5]. Its alternative name, TCONS_00015805, is a transcript identifier rather than a widely used gene alias[3]. LINC01400 is catalogued in major databases under the long intergenic non-coding RNA family, and, like many lincRNAs, may potentially be implicated in regulatory or disease processes, but this has not been established as of the current literature[3][5][9].

Other names
TCONS_00015805
02

Biological functions

Other (function not well characterized)
03

Disease associations

Other (potential cancer association, not established)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1400 (LINC01400).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1400 (LINC01400).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call